Note : les liens hypertextes menant vers d'autres sites ne sont pas mis à jour de façon continue. Il est possible qu'un lien devienne introuvable. Veuillez alors utiliser les outils de recherche pour retrouver l'information désirée.
Bibliographie
Ask DrWeil, Polaris Health (Ed). Q & A Library – A cure for Crohn's disease?, DrWeil.com. [Consulté le 19 octobre 2010]. www.drweil.com Association médicale du Canada (Ed). Grand public, Maladies - Maladie de Crohn, Amc.ca. [Consulté le 19 octobre 2010]. www.cma.ca Association François Aupetit. La maladie de Crohn. [Consulté le 19 octobre 2010]. http://afa.asso.fr Blumenthal M, Goldberg A, Brinckmann J (Ed). Expanded Commission E Monographs, American Botanical Council, publié en collaboration avec Integrative Medicine Communications, États-Unis, 2000. Crohn's and colitis foundation of america. Disease and research information, Medical information - Diet and nutrition, Crohn's and colitis foundation of america. [Consulté le 19 octobre 2010]. www.ccfa.org InteliHealth (Ed). Health A-Z - Crohn's disease, Aetna Intelihealth. [Consulté le 19 octobre 2010]. www.intelihealth.com Mayo Foundation for Medical Education and Research (Ed). Diseases & Conditions – Crohn’s disease, MayoClinic.com. [Consulté le 19 octobre 2010]. www.mayoclinic.com National Institutes of Health. National Digestive Diseases Information Clearinghouse - Crohn’s disease, Medline Plus. [Consulté le 19 octobre 2010]. www.niddk.nih.gov National Library of Medicine (Ed). Medline Plus Health Information, Health topics (ou autre) - Crohn's disease, Medline plus. [Consulté le 19 octobre 2010]. www.nlm.nih.gov National Library of Medicine (Ed). PubMed, NCBI. [Consulté le 19 octobre 2010]. www.ncbi.nlm.nih.gov UpToDate. For patients – Crohn’s disease, UpToDate. [Consulté le 19 octobre 2010]. www.uptodate.com Natural Standard (Ed). Medical Conditions – Crohn’s disease, Nature Medicine Quality Standards. [Consulté le 19 octobre 2010]. www.naturalstandard.com Pizzorno JE Jr, Murray Michael T (Ed). Textbook of Natural Medicine, Churchill Livingstone, États-Unis, 2006. The Natural Pharmacist (Ed). Natural Products Encyclopedia, Conditions - Crohn's disease, ConsumerLab.com. [Consulté le 19 octobre 2010]. www.consumerlab.com Haute Autorité de santé (France). Guide médecin sur la maladie de Crohn. Mai 2008. [Consulté le 19 octobre 2010] www.has-sante.fr
Notes
1. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Bernstein CN, Wajda A, et al. Am J Gastroenterol. 2006 Jul;101(7):1559-68. 2. Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease. Sadowski DC, Bernstein CN, et al. Can J Gastroenterol. 2009 Mar;23(3):185-202. Review. 3. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 1999 Oct;94(10):2961-5. 4. Mayo Foundation for Medical Education and Research (Ed). Diseases & Conditions – Crohn’s disease, MayoClinic.com. [Consulté le 19 octobre 2010]. www.mayoclinic.com 5. Pizzorno JE Jr, Murray Michael T (Ed). Textbook of Natural Medicine, Churchill Livingstone, États-Unis, 2006, p. 18204. 6. New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options? Vavricka SR, Rogler G. Swiss Med Wkly. 2009 Sep 19;139(37-38):527-34. Review. 7. Gerhardt H, Seifert F, et al. [Therapy of active Crohn disease with Boswellia serrata extract H 15]. [Article en allemand, résumé en anglais]. Z Gastroenterol 2001 Jan;39(1):11-7. 9. MacLean CH, Mojica WA, Newberry SJ. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr. 2005 Sep;82(3):611-9. Review. 10. Prantera C, Scribano ML, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002 Sep;51(3):405-9. 11. Mitsuyama K, Toyonaga A, Sata M. Intestinal microflora as a therapeutic target in inflammatory bowel disease. J Gastroenterol. 2002 Nov;37 Suppl 14:73-7. 12. Marteau P, Seksik P, Shanahan F. Manipulation of the bacterial flora in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2003 Feb;17(1):47-61. Review. 13. Ask DrWeil, Polaris Health (Ed). Q & A Library – A cure for Crohn's disease?, DrWeil.com. [Consulté le 19 octobre 2010]. www.drweil.com 14. Pizzorno JE Jr, Murray Michael T (Ed). Textbook of Natural Medicine, Churchill Livingstone, États-Unis, 1999, p. 1335-1349. 15. Role of diet in the management of inflammatory bowel disease. Rajendran N, Kumar D. World J Gastroenterol. 2010 Mar 28;16(12):1442-8. Review.. 16. Omer B, Krebs S, Omer H, Noor TO. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. Phytomedicine. 2007 Feb;14(2-3):87-95. Epub 2007 Jan 19. Étude décrite dans : Minigh J. Steroid-Sparing Effect of Wormwood in Cronh’s Disease. HerbalGram, no 77, Février-Avril 2008. 17. von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006 Dec;12(12):1175-84. Review. 18. The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Lidar M, Langevitz P, Shoenfeld Y. Isr Med Assoc J. 2009 Sep;11(9):558-63. Review. 19. Does evidence exist to include dietary therapy in the treatment of Crohn's disease? Brown AC, Roy M. Expert Rev Gastroenterol Hepatol. 2010 Apr;4(2):191-215. Review. 20. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Jantchou P, Morois S, Clavel-Chapelon F, et al. Am J Gastroenterol. 2010 Oct;105(10):2195-201. Epub 2010 May 11. 21. Association François Aupetit (AFA). Vaincre la maladie de Crohn et la recto-colite hémorragique. _Consulté le 19 octobre 2010_. www.afa.asso.fr 22. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial. Krebs S, Omer TN, Omer B. Phytomedicine. 2010 Apr;17(5):305-9. Epub 2009 Dec 3. 23. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Turner D, Zlotkin SH, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006320. Review. 24. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. McFarland LV. World J Gastroenterol. 2010 May 14;16(18):2202-22. Review. 25. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: Good safety profile but lack of efficacy. Holtmeier W, Zeuzem S, et al. Inflamm Bowel Dis. 2010 May 19. 26. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study. Joos S, Brinkhaus B, et al. Digestion. 2004;69(3):131-9. Epub 2004 Apr 26. 27. Acupuncture treatment in gastrointestinal diseases: a systematic review. Schneider A, Streitberger K, Joos S. World J Gastroenterol. 2007 Jul 7;13(25):3417-24. Review. 28. Treatment of inflammatory bowel disease: a role for hypnotherapy? Miller V, Whorwell PJ. Int J Clin Exp Hypn. 2008 Jul;56(3):306-17. 29. Gastroenterology. 2011 May;140(6):1785-94. doi: 10.1053/j.gastro.2011.01.055. Epidemiology and natural history of inflammatory bowel diseases. Cosnes J1, Gower-Rousseau C, Seksik P, Cortot A. 30. Am J Gastroenterol. 2010 Dec;105(12):2610-6. doi: 10.1038/ajg.2010.303. Epub 2010 Aug 10. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Margolis DJ1, Fanelli M, Hoffstad O, Lewis JD. 31. BMJ. 2013 Nov 14;347:f6633. doi: 10.1136/bmj.f6633. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. Khalili H1, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT. 32. Am J Gastroenterol. 2011 Apr;106(4):563-73. doi: 10.1038/ajg.2011.44. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Hou JK1, Abraham B, El-Serag H. 33. Scand J Gastroenterol. 2010 Dec;45(12):1464-71. doi: 10.3109/00365521.2010.510575. Epub 2010 Aug 12. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. López-Serrano P1, Pérez-Calle JL, Pérez-Fernández MT, Fernández-Font JM, Boixeda de Miguel D, Fernández-Rodríguez CM. 34. Arch Pediatr Adolesc Med. 2001 Mar;155(3):354-9. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Davis RL1, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen R;Vaccine Safety Datalink Team.